03 October 2022

Amedeo Smart

Independent Medical Education


Subscriber: th..@boehringer-ingelheim.com

HIV Infection

03 October 2022 | n=25

  1. Venter F, Sokhela S, Calmy A, Siedner MJ, et al.
    Response to comments by Taramasso and colleagues on weight gain stopping/switch rules for antiretroviral clinical trials.
    AIDS 2022;36:1900-1901.

  2. Taramasso L, Di Biagio A, Guaraldi G.
    Response to: weight gain stopping/switch rules for antiretroviral clinical trials.
    AIDS 2022;36:1899-1900.

  3. Ahluwalia AK, Inzaule S, Baggaley RC, Vitoria M, et al.
    Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxis.
    AIDS 2022;36:1897-1898.

  4. Carraro A, Belvisi V, Garattini S, Cacace S, et al.
    A case of primary central nervous system lymphoma in advanced naive HIV-infected patient: the role of antiviral agents.
    AIDS 2022;36:1895-1896.

  5. Kowalska JD, Rukhadze N, Sojak L, Bociaga-Jasik M, et al.
    Preliminary report on the provision of HIV care to war refugees with HIV who are migrating from Ukraine: data from the ECEE Network Group.
    AIDS 2022;36:1887-1890.

  6. Xia Q, Edelstein ZR, Blumenthal JS.
    Improving HIV preexposure prophylaxis implementation within healthcare settings.
    AIDS 2022;36:1883-1885.

  7. Duarte FC, Moura LM, Laranjinha J.
    High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy.
    AIDS 2022;36:1881-1882.

  8. Laeremans T, D'haese S, Aernout J, Barbe K, et al.
    Qualitative plasma viral load determination as a tool for screening of viral reservoir size in PWH.
    AIDS 2022;36:1761-1768.

  9. Satish S, Bravo L, McAllister A, Teitelman A, et al.
    Provision of HIV pre-exposure prophylaxis to female patients seeking family planning services in the United States.
    AIDS 2022.

  10. Hagenimana M, Kodan AE, George N, Businge L, et al.
    Cancer in patients with and without HIV infection in the national cancer registry of Rwanda.
    AIDS 2022.

  11. Lumu I, Musaazi J, Castelnuovo B.
    Durability of switched therapy after failure of WHO-recommended antiretroviral therapy regimens in a resource-limited setting.
    AIDS 2022;36:1791-1800.

  12. Tagliaferri Rael C, Giguere R, Sutton S, Horn E, et al.
    Preferences for a Long-Acting, Removable Implant for HIV Prevention among MSM and Physicians: A Discrete Choice Study.
    AIDS Res Hum Retroviruses 2022.

  13. Zhao R, Ma R, Zhao C, Zhang Q, et al.
    Risk factors for Osteonecrosis of the femoral head in HIV positive patients: A retrospective case-control study.
    AIDS Res Hum Retroviruses 2022.

  14. Sharafi M, Mirahmadizadeh A, Hassanzadeh J, Seif M, et al.
    Prevalence of Late Presenters and Advanced HIV disease in HIV patients and their related factors in Iran: Results from 19 years of national surveillance HIV data.
    AIDS Res Hum Retroviruses 2022.

  15. Harrison TS, Lawrence DS, Mwandumba HC, Boulware DR, et al.
    How applicable is the single-dose AMBITION regimen for HIV-associated cryptococcal meningitis to high-income settings?
    Clin Infect Dis 2022.

  16. Kuehn BM.
    Interim Guidance for Monkeypox Among Patients With HIV.
    JAMA 2022;328:1173-1174.

  17. Nevrekar N, Butler K, Shapiro DE, Atuhaire P, et al.
    Self-Reported Antiretroviral Adherence: Association with Maternal Viral Load Suppression in Postpartum Women Living with HIV-1 from Promoting Maternal and Infant Survival Everywhere (PROMISE), a Randomized Controlled Trial in Sub-Saharan Africa and In
    J Acquir Immune Defic Syndr 2022.

  18. Cranmer LM, Njuguna IN, LaCourse SM, Figueroa J, et al.
    Performance of Tuberculosis symptom screening among hospitalized ART-naive Children with HIV in Kenya.
    J Acquir Immune Defic Syndr 2022.

  19. Wang G, Song W, Rao S, Heitgerd J, et al.
    HIV Positivity, Linkage to Medical Care, Interview for Partner Services, and Pre-exposure Prophylaxis Awareness and Referral among Men Who Have Sex with Men Tested in Non-healthcare Settings in the United States, 2019.
    J Acquir Immune Defic Syndr 2022.

  20. Vyas KJ, Marconi VC, Moanna A, Rimland D, et al.
    Trends in Cause-Specific Mortality among Veterans with HIV: A 35-Year (1982-2016) Analysis of the HIV Atlanta VA Cohort Study.
    J Acquir Immune Defic Syndr 2022.

  21. Uriu K, Cardenas P, Munoz E, Barragan V, et al.
    Characterization of the Immune Resistance of Severe Acute Respiratory Syndrome Coronavirus 2 Mu Variant and the Robust Immunity Induced by Mu Infection.
    J Infect Dis 2022;226:1200-1203.

  22. Hermanussen L, Grewe I, Tang HT, Norz D, et al.
    Tecovirimat therapy for severe monkeypox infection: Longitudinal assessment of viral titers and clinical response pattern - A first case-series experience.
    J Med Virol 2022.

  23. Shchemelev AN, Boumbaly S, Ostankova YV, Zueva EB, et al.
    Prevalence of drug resistant HIV-1 forms in patients without any history of ART in the Republic of Guinea.
    J Med Virol 2022.

  24. Nguyen HT, Kuse N, Zhang Y, Murakoshi H, et al.
    Control of HIV-1 Replication by CD8(+) T Cells Specific for Two Novel Pol Protective Epitopes in HIV-1 Subtype A/E Infection.
    J Virol 2022.

  25. Waters L, Dewsnap C.
    Young women and anal sex: healthcare professionals must normalise questions about what is normal for many people.
    BMJ 2022;378:o2323.


Display articles in


Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:



Amedeo HIV Infection

Five-Week Literature

25 March 2024

18 March 2024

11 March 2024

04 March 2024

26 February 2024


03 October 2022

Multidisciplinary Journal Club

  1. Nathan DM, Lachin JM, Bebu I, Burch HB, et al.
    Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.
    N Engl J Med. 2022;387:1075-1088.

  2. Bhatt DL, Vaduganathan M, Kandzari DE, Leon MB, et al.
    Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
    Lancet. 2022 Sep 16. pii: S0140-6736(22)01787.

  3. Ailani J, Kaiser EA, Mathew PG, McAllister P, et al.
    Role of Calcitonin Gene-Related Peptide on the Gastrointestinal Symptoms of Migraine-Clinical Considerations: A Narrative Review.
    Neurology. 2022 Sep 20. pii: WNL.0000000000201332.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.


Privacy Policy